eicosapentaenoic acid ethyl ester has been researched along with Cognitive Dysfunction in 2 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stilling, F | 1 |
| Wolk, A | 1 |
| Religa, D | 1 |
| Leppert, J | 1 |
| Bergkvist, L | 1 |
| Michaëlsson, K | 1 |
| Larsson, SC | 1 |
| Coley, N | 1 |
| Raman, R | 1 |
| Donohue, MC | 1 |
| Aisen, PS | 1 |
| Vellas, B | 1 |
| Andrieu, S | 1 |
2 other studies available for eicosapentaenoic acid ethyl ester and Cognitive Dysfunction
| Article | Year |
|---|---|
Adipose tissue fatty acid composition and cognitive impairment.
Topics: Adipose Tissue; Aged, 80 and over; Arachidonic Acid; Cognitive Dysfunction; Cross-Sectional Studies; | 2018 |
Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Topics: Activities of Daily Living; Aged; Cognition; Cognitive Dysfunction; Dementia; Dietary Supplements; D | 2018 |